Eltrombopag in Good's Syndrome.

Categoría Estudio primario
RevistaCase reports in hematology
Año 2014
Good's syndrome is a rare acquired immunodeficiency associated with thymoma. Eltrombopag is a thrombopoietin receptor agonist and has been shown to be a valuable supplement to the treatment of several types of refractory cytopenias. In this paper, we describe a male patient suffering from Good's syndrome with immune-mediated T-cell driven pancytopenia and absence of megakaryopoiesis. He was successfully treated with eltrombopag resulting in a multilineage clinical response.
Epistemonikos ID: d9fe87ec69e4485e406c73f99373d18fd3dfc2ee
First added on: Dec 01, 2021